Essa Pharma
Investors/Media

With a focus on the development of small molecule drugs for the treatment of cancer, the goal at ESSA is to develop a pipeline of oncology therapeutics. We will continue to research innovative ideas with the goal of providing a promising future for the patients and community we serve.

With a focus on the development of small molecule drugs for the treatment of cancer, the goal at ESSA is to develop a pipeline of oncology therapeutics. We will continue to research innovative ideas with the goal of providing a promising future for the patients and community we serve.

Latest News
Sep 13, 2022
ESSA Pharma Appoints Philip Kantoff to its Board of Directors

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the...

Aug 4, 2022
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2022

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a...

Jun 30, 2022
ESSA Pharma Insiders Establish Automatic Securities Disposition Plans

ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that...

View All News

View All

Stock Performance

Last Price

Change

Volume

NASDAQEPIX
Learn More

Investor & Media Contacts

INVESTORS
Xuan Yang
Solebury Trout
xyang@soleburytrout.com

MEDIA
Zara Lockshin
Solebury Trout
zlockshin@soleburytrout.com